NF-kB and IKK as Key Mediators of Inflammation and Oncogenic Progression - Transcription Factors NF-kappaB - page 172

[50] Munzenmaier, A. et al., A secreted/shed product of H. pylori activates transcription

factor NF-κB, J. Immunol ., 159, 6140, 1997.

[51] Ishihara, S. et al., Essential role of MD2 in TLR4-dependent signaling during H.

pylori -associated gastritis, J. Immunol ., 173, 1406, 2004.

[52] Viala, J. et al., Nod1 responds to peptidoglycan delivery by H. pylori cag pathoge-

nicity island, Nat. Immunol ., 5, 1166, 2004.

[53] Mokdad, A.H. et al., Prevalence of obesity, diabetes, and obesity-related health risk

factors, JAMA, 289, 76, 2003.

[54] Hotamisligil, G.S., Inflammatory pathways and insulin action, Int. J. Obes. Relat.

Metab. Disord., 27, S53, 2003.

[55] Hanahan, D. and Weinberg, R., The hallmarks of cancer, Cell, 100, 57, 2000.

[56] Campbell, P.M. and Der, C.J., Oncogenic Ras and its role in tumor cell invasion and

metastasis, Semin. Cancer Biol ., 14, 105, 2004.

[57] Evan, G. and Vousden, K., Proliferation, cell cycle and apoptosis in cancer, Nature,

411, 342, 2001.

[58] Shay, J.W. and Bacchetti, S., A survey of telomerase activity in human cancer, Eur.

J. Cancer, 33, 787, 1997.

[59] Johnsen, M. et al., Cancer invasion and tissue remodeling: Common themes in

proteolytic matrix degradation, Curr. Opin. Cell Biol ., 10, 667, 1998.

[60] Hay, E.D., An overview of epithelio-mesenchymal transformation, Acta Anat ., 154,

8, 1995.

[61] Thiery, J.P., Epithelial-mesenchymal transitions in tumor progression, Nat. Rev. Can-

cer, 2, 442, 2003.

[62] Coussens, L. and Werb, Z., Inflammation and cancer, Nature, 420, 860, 2002.

[63] Turini, M.E. and Dubois, R.N., Cyclooxygenase-2: A therapeutic target, Ann. Rev.

Med ., 53, 35, 2002.

[64] Greten, F.R. et al., IKKβ links inflammation and tumorigenesis in a mouse model of

colitis-associated cancer, Cell, 118, 285, 2004.

[65] Pikarsky, E. et al., NF-κB functions as a tumor promoter in inflammation-associated

cancer, Nature, 353, 180, 2004.

[66] Clevers, H., At the crossroads of inflammation and cancer, Cell, 118, 671, 2004.

[67] Rutter, M. et al., Severity of inflammation is a risk for colorectal neoplasia in

ulcerative colitis, Gastroenterology, 126, 451, 2004.

[68] Bissell, M. and Radisky, D., Putting tumors in context, Nat. Rev. Cancer, 1, 46, 2001.

[69] Balkwill, F., Charles, K., and Mantovani, A., Smoldering and polarized inflammation

in the initiation and promotion of malignant disease, Cancer Cell, 7, 211, 2005.

[70] Sparmann, A. and Bar-Sagi, D., Ras-induced IL-8 expression plays a critical role in

tumor growth and angiogenesis, Cancer Cell, 6, 447, 2004.

[71] Alcamo et al., Targeted mutation of the TNF receptor 1 rescues the RelA-deficient

mouse and reveals a critical role for NF-κB in leukocyte recruitment, J. Immunol .,
167, 1592, 2001.

[72] Grigoriadis, G. et al., The Rel subunit of NF-κB-like transcription factors is a positive

and negative regulator of macrophage gene expression: Distinct roles for Rel in
different macrophage populations, Embo J ., 15, 7099, 1996.

[73] Grossmann, M. et al., The combined absence of the transcription factor Rel and RelA

leads to multiple hemopoietic cell defects, Proc. Nat. Acad. Sci. USA, 96, 11848,
1999.

[74] Lawrence, T. et al., Possible new role for NF-κB in the resolution of inflammation,

Nat. Med ., 7, 1291, 2001.